BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38548179)

  • 1. Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making.
    Gauvreau CL; Schreyer L; Gibson PJ; Koo A; Ungar WJ; Regier D; Chan K; Hayeems R; Gibson J; Palmer A; Peacock S; Denburg AE
    Value Health; 2024 Jul; 27(7):879-888. PubMed ID: 38548179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
    Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
    BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.
    Gauvreau CL; Wight L; Subasri M; Palmer A; Hayeems R; Croker A; Abelson J; Fraser B; Bombard Y; Moore Hepburn C; Wilson MG; Denburg A
    Health Expect; 2023 Apr; 26(2):715-727. PubMed ID: 36639959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
    Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
    Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes.
    Baltussen R; Jansen MPM; Bijlmakers L; Grutters J; Kluytmans A; Reuzel RP; Tummers M; der Wilt GJV
    Value Health; 2017 Feb; 20(2):256-260. PubMed ID: 28237205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicriteria decision analysis in health care decision in oncology: a systematic review.
    Campolina AG; Suzumura EA; Hong QN; de Soárez PC
    Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):365-380. PubMed ID: 34913775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-Oriented Health Technology Assessment: One Step Forward in Supporting the Decision-Making Process in Hospitals.
    Ritrovato M; Faggiano FC; Tedesco G; Derrico P
    Value Health; 2015 Jun; 18(4):505-11. PubMed ID: 26091605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients.
    Goetghebeur MM; Wagner M; Khoury H; Rindress D; Grégoire JP; Deal C
    Cost Eff Resour Alloc; 2010 Apr; 8():4. PubMed ID: 20377888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy.
    Denburg AE; Giacomini M; Ungar W; Abelson J
    Int J Health Policy Manag; 2022 Mar; 11(3):374-382. PubMed ID: 32801223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-criteria development and incorporation into decision tools for health technology adoption.
    Poulin P; Austen L; Scott CM; Waddell CD; Dixon E; Poulin M; Lafrenière R
    J Health Organ Manag; 2013; 27(2):246-65. PubMed ID: 23802401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework.
    Angelis A; Linch M; Montibeller G; Molina-Lopez T; Zawada A; Orzel K; Arickx F; Espin J; Kanavos P
    Soc Sci Med; 2020 Feb; 246():112595. PubMed ID: 31874372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.
    Aryankhesal A; Behzadifar M; Bakhtiari A; Shahabi S; Azari S; Darvishi Teli B; Rezapour A; Ehsanzadeh SJ; Behzadifar M
    Health Res Policy Syst; 2024 Jan; 22(1):11. PubMed ID: 38225573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
    Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
    Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model-based study to estimate the health and economic impact of health technology assessment in Thailand.
    Kingkaew P; Budtarad N; Khuntha S; Barlow E; Morton A; Isaranuwatchai W; Teerawattananon Y; Painter C
    Int J Technol Assess Health Care; 2022 May; 38(1):e45. PubMed ID: 35506420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all.
    Pericleous L; Amin M; Goeree R
    J Med Econ; 2019 May; 22(5):478-487. PubMed ID: 30757934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
    Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
    Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.
    Angelis A; Thursz M; Ratziu V; O'Brien A; Serfaty L; Canbay A; Schiefke I; Costa JBE; Lecomte P; Kanavos P
    Med Decis Making; 2020 Aug; 40(6):830-845. PubMed ID: 32845234
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
    Angelis A; Montibeller G; Hochhauser D; Kanavos P
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.